Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Clinical Trial ID NCT02641093

PubWeight™ 2.32^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02641093

Top papers